Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 16 Breast Neoplasms 10 Brain Neoplasms 7 Neoplasms 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Urinary Bladder Neoplasms 3 Spinal Cord Neoplasms 3 Multiple Myeloma 2 Lymphoma, B-Cell 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocythemia, Essential 1 Thoracic Neoplasms 1 Thoracic Diseases 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Diseases 1 Solid Tumor, Adult 1 Sinusitis 1 Sarcoma 1

Interventions

Temozolomide 45 Radiotherapy 16 Carboplatin 15 Irinotecan 12 Carmustine 12 Bevacizumab 12 Filgrastim 10 Vincristine 9 Surgical Procedures, Operative 9 Magnetic Resonance Spectroscopy 9 Procarbazine 7 Peripheral Blood Stem Cell Transplantation 6 Imatinib Mesylate 6 Erlotinib Hydrochloride 6 temsirolimus 5 sargramostim 5 O(6)-benzylguanine 5 Lomustine 5 Flucytosine 5 Etoposide 5 Thiotepa 4 Sirolimus 4 Cyclophosphamide 4 aldesleukin 3 Thalidomide 3 Surveys and Questionnaires 3 Sunitinib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Polymerase Chain Reaction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Oligodendroglioma × Magnetic Resonance Imaging × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡